Clinical Trials Directory

Trials / Completed

CompletedNCT03500718

Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research · Other Government
Sex
All
Age
1 Year – 6 Years
Healthy volunteers
Accepted

Summary

After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).This ECAP is measured intra operatively, after 4 weeks( at switch on), after 3months and 6 months following cochlear implantation.

Detailed description

After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).This ECAP is measured intra operatively, 4 weeks(at switch on) and after 3months and 6 months following cochlear implantation. Neural Response Telemetry (NRT) is a quick and non-invasive way of recording ECAP of the peripheral auditory nerves in-situ. It gives clinicians valuable information for programming the T- (Threshold) and C-(Comfort) - levels of the recipient's speech processor map. Intraoperative NRT in conjunction with electrode impedance data can help indicate the integrity of the implanted electrodes and the electrode/auditory nerve interface, confirming that the implant is functioning correctly intraoperatively.

Conditions

Interventions

TypeNameDescription
DEVICECochlear implantAfter cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).

Timeline

Start date
2018-02-26
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-04-18
Last updated
2020-02-24

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03500718. Inclusion in this directory is not an endorsement.